Imaging for diagnosis, staging and response assessment of Hodgkin lymphoma and non-Hodgkin lymphoma

@article{McCarten2019ImagingFD,
  title={Imaging for diagnosis, staging and response assessment of Hodgkin lymphoma and non-Hodgkin lymphoma},
  author={K. McCarten and H. Nadel and B. Shulkin and Steve Y. Cho},
  journal={Pediatric Radiology},
  year={2019},
  volume={49},
  pages={1545 - 1564}
}
Hodgkin lymphoma and non-Hodgkin lymphoma are common malignancies in children and are now highly treatable. Imaging plays a major role in diagnosis, staging and response using conventional CT and MRI and metabolic imaging with positron emission tomography (PET)/CT and PET/MRI. Cross-sectional imaging has replaced staging laparotomy and splenectomy by demonstrating abdominal nodal groups and organ involvement. [F-18]2-fluoro-2-deoxyglucose (FDG) PET provides information on bone marrow… Expand
Overview and recent advances in PET/CT imaging in lymphoma and multiple myeloma.
TLDR
An overview of the role of [18 F] FDG-PET, in hematological malignancies is provided, particularly focusing on Hodgkin lymphoma and Diffuse Large B Cell Lymphoma, both in adult and pediatric populations, and MM, at each point of patient management. Expand
Whole-body [18F]-FDG-PET/MRI for staging of pediatric non-Hodgkin lymphoma: first results from a single-center evaluation
TLDR
Despite the small number of cases evaluated, whole-body [ 18 F]-FDG-PET turned out to be a valuable tool for staging of pediatric non-Hodgkin lymphoma. Expand
Direct comparison of diagnostic accuracies of F-18 FDG PET and MRI for detection of bone marrow involvement in lymphoma patients; A meta-analysis.
TLDR
F-18 FDG PET or PET/CT and MRI showed similar diagnostic performances for the detection of BMI in lymphoma patients, and further large multicenter studies would be necessary to substantiate the diagnostic accuracy. Expand
Prognostic value of imaging markers from 18FDG-PET/CT in paediatric patients with Hodgkin lymphoma.
TLDR
Four textural features were found as candidates for predicting early response to chemotherapy in paediatric patients with HL, and the Deauville score at iPET was useful for differentiating PFS rates. Expand
Whole-Body PET/MRI Applications in Pediatric Oncology.
TLDR
The strengths of PET/MRI over PET/CT are compelling and include decreased radiation exposure, decreased number of sedation and general anesthesia events, single-day one-stop visits, and simultaneous imaging with two stand-alone advanced imaging techniques essential to staging and assessing treatment response in pediatric oncology. Expand
PET/CT in pediatric oncology.
TLDR
The applications of PET/CT for imaging the most common pediatric neoplasms are reviewed to review the shortage of large trials and the fear of long-term radiation effects on this peculiar category of patients. Expand
MDCT evaluation of synchronous breast carcinoma and other solid malignancies.
TLDR
Patients with breast carcinoma have a risk of other synchronous primary malignancy and careful preoperative examination is recommended to improve the patients' prognosis. Expand
Emerging Roles of PET/MR in the Pediatric Hospital.
TLDR
PET/MR is beneficial particularly in pediatric patients who undergo recurrent imaging, such as those with cancer or chronic inflammatory disease, and may have a role in diagnosis and management of infectious and inflammatory conditions relevant to the pediatric population. Expand
Update on Hodgkin lymphoma from a radiologist's perspective.
TLDR
The purpose of this article is to provide radiologists with an update on the current role of imaging in Hodgkin lymphoma from diagnosis to assessment of treatment response, in view of the new staging and response assessment system and current treatment strategies. Expand
Multiple ectopic goiter in the retroperitoneum, abdominal wall, liver, and diaphragm: A case report and review of literature
TLDR
Multiple para-ectopic thyroid is often misdiagnosed, owing to its extremely rare incidence and non-specific clinical manifestations and imaging features, and a combination of multiple examinations is necessary for diagnostic accuracy. Expand
...
1
2
...

References

SHOWING 1-10 OF 59 REFERENCES
[18F]Fluorodeoxyglucose positron emission tomography for detection of bone marrow involvement in children and adolescents with Hodgkin's lymphoma.
TLDR
FDG-PET is a sensitive and specific method for the detection of BM involvement in pediatric HL and may safely be substituted for a BMB in routine staging procedures. Expand
Recommendations for initial evaluation, staging, and response assessment of Hodgkin and non-Hodgkin lymphoma: the Lugano classification.
  • B. Cheson, R. Fisher, +4 authors T. Lister
  • Medicine
  • Journal of clinical oncology : official journal of the American Society of Clinical Oncology
  • 2014
TLDR
Recommendations to modernize recommendations for evaluation, staging, and response assessment of patients with Hodgkin lymphoma and non-Hodgkin lymphomas and enhance the ability to compare outcomes of clinical trials are made. Expand
Extranodal Hodgkin disease: spectrum of disease.
  • A. Guermazi, P. Brice, +4 authors J. Frija
  • Medicine
  • Radiographics : a review publication of the Radiological Society of North America, Inc
  • 2001
TLDR
Computed tomography (CT) is the preferred modality for evaluating hepatic lymphoma and has proved particularly valuable in diagnosing gastric lymph cancer and detecting renal or perirenal masses, although ultrasonography and magnetic resonance imaging may also be helpful. Expand
Bone marrow FDG-PET/CT in Hodgkin lymphoma revisited: do imaging and pathology match?
TLDR
This histopathological correlation study confirms the very high diagnostic value of FDG-PET/CT in the detection of bone marrow involvement in newly diagnosed Hodgkin lymphoma, and supports the substitution of BMB withFDG- PET/ CT in this setting. Expand
18F-FDG PET/CT in Lymphoma: Has Imaging-Directed Personalized Medicine Become a Reality?
TLDR
Evidence that supports PET-directed personalized approaches in lymphoma has improved outcomes in Hodgkin lymphoma, using less chemotherapy and more selective radiotherapy is summarized. Expand
Revised International Pediatric Non-Hodgkin Lymphoma Staging System.
TLDR
This revised IPNHLSS will facilitate more precise staging for children and adolescents with NHL and facilitate comparisons of efficacy across different treatment strategies, various institutions, multicenter trials, and cooperative groups by allowing for reproducible pediatric-based staging at diagnosis and relapse. Expand
Value of 18F-FDG PET and PET/CT for Evaluation of Pediatric Malignancies
TLDR
This review article will synthesize the current literature on 18F-FDG PET/CT for tumor staging in children, summarizing questions that have been solved and providing an outlook on unsolved avenues. Expand
Utility of Bone Marrow Biopsy and Aspirate for Staging of Diffuse Large B Cell Lymphoma in the Era of Positron Emission Tomography With 2‐Deoxy‐2‐[Fluorine‐18]fluoro‐deoxyglucose Integrated With Computed Tomography
TLDR
The aim of this retrospective study was to determine the accuracy of PET‐CT in detecting BMI in DLBCL and to define 2‐year and 5‐year overall survival based on BMI by BMAB versus PET‐ECT, as well as define the proportion of stage IV cases by each method. Expand
18F-FDG PET and PET/CT in Burkitt's lymphoma.
TLDR
FDG PET-PET/CT is sensitive for the detection of viable disease in Burkitt's lymphoma and affected areas demonstrated high degree of uptake that was reversible upon successful implementation of treatment. Expand
Pediatric nonlymphoblastic non-Hodgkin lymphoma: baseline, interim, and posttreatment PET/CT versus contrast-enhanced CT for evaluation--a prospective study.
TLDR
Either PET/CT or contrast-enhanced CT may be used for response assessment and prognostication in stage III or IV nonlymphoblastic pediatric NHL and results in upstaging of disease are shown. Expand
...
1
2
3
4
5
...